AllianceBernstein’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $170K | Hold |
27,720
| – | – | ﹤0.01% | 3087 |
|
|
2025
Q4 | $170K | Sell |
27,720
-3,400
| -11% | -$36.7K | ﹤0.01% | 3098 |
|
|
2025
Q3 | $574K | Hold |
31,120
| – | – | ﹤0.01% | 2606 |
|
|
2025
Q2 | $405K | Buy |
31,120
+8,320
| +36% | +$98.4K | ﹤0.01% | 2770 |
|
|
2025
Q1 | $241K | Sell |
22,800
-2,610
| -10% | -$41.4K | ﹤0.01% | 2860 |
|
|
2024
Q4 | $431K | Hold |
25,410
| – | – | ﹤0.01% | 2702 |
|
|
2024
Q3 | $590K | Hold |
25,410
| – | – | ﹤0.01% | 2580 |
|
|
2024
Q2 | $619K | Hold |
25,410
| – | – | ﹤0.01% | 2549 |
|
|
2024
Q1 | $858K | Hold |
25,410
| – | – | ﹤0.01% | 2345 |
|
|
2023
Q4 | $801K | Hold |
25,410
| – | – | ﹤0.01% | 2383 |
|
|
2023
Q3 | $649K | Sell |
25,410
-55,660
| -69% | -$1.71M | ﹤0.01% | 2441 |
|
|
2023
Q2 | $2.33M | Buy |
81,070
+58,270
| +256% | +$1.59M | ﹤0.01% | 1821 |
|
|
2023
Q1 | $547K | Hold |
22,800
| – | – | ﹤0.01% | 2524 |
|
|
2022
Q4 | $387K | Hold |
22,800
| – | – | ﹤0.01% | 2768 |
|
|
2022
Q3 | $338K | Sell |
22,800
-3,300
| -13% | -$55.4K | ﹤0.01% | 2814 |
|
|
2022
Q2 | $411K | Hold |
26,100
| – | – | ﹤0.01% | 2762 |
|
|
2022
Q1 | $704K | Hold |
26,100
| – | – | ﹤0.01% | 2546 |
|
|
2021
Q4 | $966K | Hold |
26,100
| – | – | ﹤0.01% | 2483 |
|
|
2021
Q3 | $1.25M | Sell |
26,100
-4,000
| -13% | -$179K | ﹤0.01% | 2417 |
|
|
2021
Q2 | $1.02M | Hold |
30,100
| – | – | ﹤0.01% | 2524 |
|
|
2021
Q1 | $1.24M | Hold |
30,100
| – | – | ﹤0.01% | 2326 |
|
|
2020
Q4 | $1.31M | Buy |
30,100
+14,000
| +87% | +$948K | ﹤0.01% | 2190 |
|
|
2020
Q3 | $691K | Sell |
16,100
-600
| -4% | -$29.8K | ﹤0.01% | 2354 |
|
|
2020
Q2 | $781K | Buy |
+16,700
| New | +$576K | ﹤0.01% | 2338 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
